StreetAlpha
13F holdings · Q3 2026

TCG Crossover Management

Palo Alto, CA · files as TCG Crossover Management, LLC
Know the moment TCG Crossover Management filesYou follow TCG Crossover Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1839948

TCG Crossover Management reported 57 stocks worth $3.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ABVX (10.3%), CGON (7.3%) and AMLX (5.1%). Compared with Q2 2026, the fund opened new positions in KRSA, ADRX and ENTX, added to ZLAB, MIRM and TYRA, trimmed ABVX, TNGX and COGT and sold out of RVMD, SRZN and ALT.

Latest filing: what TCG Crossover Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
8 new4 added15 trimmed5 sold outBought about $351M · sold about $625M
New 8
See all 8 →
Added 4
Trimmed 15
See all 15 →
Sold out 5

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$3.5B−14.9% vs last quarter
Stocks held578 new · 5 sold out
Top 5 weight32.3%spread out
Turnover28%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ABVX
Abivax SA
$363M10.3%3.7M−2.3M (−39%)8 of 8
2
CGON
CG Oncology Inc
$260M7.3%3.7MNo change8 of 8
3
AMLX
Amylyx Pharmaceuticals Inc
$182M5.1%6.2MNo change8 of 8
4
SYRE
Spyre Therapeutics Inc
$169M4.8%1.9MNo change5 of 8
5
TNGX
Tango Therapeutics Inc
$169M4.8%6.8M−2.3M (−25%)8 of 8
6
ZLAB
Zai Lab Ltd
$164M4.6%6.2M+91K (+1%)2 of 8
7
IMVT
Immunovant Inc
$151M4.3%4.5MNo change4 of 8
8
DNTH
Dianthus Therapeutics Inc
$148M4.2%1.7MNo change8 of 8
9
KRSA
Korsana Biosciences Inc
$146M4.1%4.5MNew position1 of 8
10
KOD
Kodiak Sciences Inc
$137M3.9%1.4MNo change8 of 8
🔒 47 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
RVMD
Revolution Medicines Inc
$63.8M341K
SRZN
Surrozen Inc
$38.2M1.5M
ALT
Altimmune Inc
$30.4M10M
FORTE BIOSCIENCES INC
$19.6M920K
RACC
Research Alliance Corp Iii Ord Shs Cl A
$5.3M500K

Reported value

last 8 quarters
$1BQ4 '24
$733MQ1 '25
$876MQ2 '25
$2BQ3 '25
$3BQ4 '25
$3.5BQ1 '26
$4.2BQ2 '26
$3.5BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

TCG Crossover Management 13F FAQ

What does TCG Crossover Management own?

TCG Crossover Management reported 57 stocks worth $3.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ABVX (10.3%), CGON (7.3%) and AMLX (5.1%). The table above lists every position in the filing (the top 10 without an account).

What did TCG Crossover Management buy and sell in Q3 2026?

Compared with Q2 2026: 8 new positions, 4 added to, 15 trimmed and 5 sold out. New positions include KRSA, ADRX and ENTX. It sold all of RVMD, SRZN and ALT.

When will TCG Crossover Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is TCG Crossover Management's portfolio worth?

The Q3 2026 filing reports $3.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.